Association Between Immunosuppressive Therapy and Incident Risk of Interstitial Lung Disease in Systemic Sclerosis

S Hoa; S Bernatsky; M Baron; S Proudman; W Stevens; J Sahhar; M Wang; RJ Steele; M Hudson; G Gyger; J Pope; M Larché; N Khalidi; A Masetto; E Sutton; TS Rodriguez-Reyna; N Maltez; C Thorne; PR Fortin; A Ikic; D Robinson; N Jones; S LeClercq; JP Mathieu; P Docherty; D Smith; M Fritzler; L Croyle; J de Jager; N Ferdowsi; C Hill; R Laurent; S Lester; G Major; K Morrisroe; P Nash; G Ngian; M Nikpour; M Rischmueller; J Roddy; L Schrieber; W Stevens; G Strickland; A Sturgess; V Thakkar; K Tymms; J Walker; P Youseff; J Zochling

Journal article

Association Between Immunosuppressive Therapy and Incident Risk of Interstitial Lung Disease in Systemic Sclerosis

S Hoa, S Bernatsky, M Baron, S Proudman, W Stevens, J Sahhar, M Wang, RJ Steele, M Hudson, G Gyger, J Pope, M Larché, N Khalidi, A Masetto, E Sutton, TS Rodriguez-Reyna, N Maltez, C Thorne, PR Fortin, A Ikic Show all

Chest | ELSEVIER | Published : 2021

DOI: 10.1016/j.chest.2021.06.014

University of Melbourne Researchers

Wendy Stevens Author

Katie Morrisroe Author

Mandana Nikpour Author

Related Projects (1)

IMPROVING OUTCOMES IN SYSTEMIC AUTOIMMUNE DISEASE: A COLLABORATIVE AND INTERDISCIPLINARY PROGRAM OF RESEARCH

The multi-organ autoimmune diseases ‘scleroderma’ and ‘lupus’ have a profound negative impact on quality of life and life expectancy. The ov..

Grants

Awarded by Scleroderma Foundation

Citation metrics

10Scopus

8Web of Science

10Dimensions

Keywords

3211 Oncology and Carcinogenesis

Lung

Australian Scleroderma Interest Group (asig)

Life Sciences & Biomedicine

General & Internal Medicine

Autoimmune Disease

32 Biomedical and Clinical Sciences

Canadian Scleroderma Research Group (csrg)

Critical Care Medicine

Respiratory